Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecules (Basel, Switzerland)|January 20, 2021
A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico InsightsMohammad M Al-Sanea, Ahmad J Obaidullah, Mohamed E Shaker, et al.
Archiv Der Pharmazie|December 4, 2021
Targeting VEGFR-2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studiesNawaf A Alsaif, Hazem A Mahdy, Mohammed M Alanazi, et al.
Bioorganic Chemistry|March 18, 2019
Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitorsAdel S El-Azab, Alaa A-M Abdel-Aziz, Sivia Bua, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 4, 2020
Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitorsAdel S El-Azab, Alaa A-M Abdel-Aziz, Hany E A Ahmed, et al.
Bioorganic Chemistry|March 29, 2019
Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivativesAlaa A-M Abdel-Aziz, Adel S El-Azab, Silvia Bua, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 20, 2020
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitorsAdel S El-Azab, Alaa A-M Abdel-Aziz, Silvia Bua, et al.
Pageof 5